Answer the questions
Since January 2020 Elsevier has created a COVID-19 resource centre with
free information in English and Mandarin on the novel coronavirus COVID-
19. The COVID-19 resource centre is hosted on Elsevier Connect, the
company's public news and information website.
Elsevier hereby grants permission to make all its COVID-19-related
research that is available on the COVID-19 resource centre - including this
research content - immediately available in PubMed Central and other
publicly funded repositories, such as the WHO COVID database with rights
for unrestricted research re-use and analyses in any form or by any means
with acknowledgement of the original source. These permissions are
granted for free by Elsevier for as long as the COVID-19 resource centre
remains active.
International Journal of Nursing Studies 108 (2020) 103629
Contents lists available at ScienceDirect
International Journal of Nursing Studies
j o u r n a l h o m e p a g e : w w w . e l s e v i e r . c o m / i j n s
A rapid systematic review of the efficacy of face masks and respirators
against coronaviruses and other respiratory transmissible viruses for
the community, healthcare workers and sick patients
C. Raina MacIntyre a , Abrar Ahmad Chughtai b , ∗
a The Kirby Institute, UNSW Medicine, University of New South Wales, Sydney, Australia b School of Public Health and Community Medicine, UNSW Medicine, University of New South Wales, Room 228, Level 2 Samuels Building, Sydney, Australia
a r t i c l e i n f o
Article history:
Received 24 March 2020
Received in revised form 18 April 2020
Accepted 21 April 2020
Keywords:
Coronavirus
Coronavirus disease
COVID19
Mask
Respirators
Personal protective equipment
a b s t r a c t
Background: The pandemic of COVID-19 is growing, and a shortage of masks and respirators has been
reported globally. Policies of health organizations for healthcare workers are inconsistent, with a change
in policy in the US for universal face mask use. The aim of this study was to review the evidence around
the efficacy of masks and respirators for healthcare workers, sick patients and the general public.
Methods: A systematic review of randomized controlled clinical trials on use of respiratory protection by
healthcare workers, sick patients and community members was conducted. Articles were searched on
Medline and Embase using key search terms.
Results: A total of 19 randomised controlled trials were included in this study – 8 in community set-
tings, 6 in healthcare settings and 5 as source control. Most of these randomised controlled trials used
different interventions and outcome measures. In the community, masks appeared to be effective with
and without hand hygiene, and both together are more protective. Randomised controlled trials in health
care workers showed that respirators, if worn continually during a shift, were effective but not if worn
intermittently. Medical masks were not effective, and cloth masks even less effective. When used by sick
patients randomised controlled trials suggested protection of well contacts.
Conclusion: The study suggests that community mask use by well people could be beneficial, particularly
for COVID-19, where transmission may be pre-symptomatic. The studies of masks as source control also
suggest a benefit, and may be important during the COVID-19 pandemic in universal community face
mask use as well as in health care settings. Trials in healthcare workers support the use of respirators
continuously during a shift. This may prevent health worker infections and deaths from COVID-19, as
aerosolisation in the hospital setting has been documented.
© 2020 The Author(s). Published by Elsevier Ltd.
This is an open access article under the CC BY-NC-ND license.
( http://creativecommons.org/licenses/by-nc-nd/4.0/ )
W
a
W
h
0
(
hat is already known about the topic?
• Masks and respirators are commonly used to protect from res- piratory infections in three different indications – for healthcare
workers, sick patients and well community members.
• Currently there is debate and conflicting guidelines around the use of masks and respirators in healthcare and community set-
tings.
∗ Corresponding author. E-mail addresses: r.macintyre@unsw.edu.au (C.R. MacIntyre),
brar.chughtai@unsw.edu.au (A .A . Chughtai).
ttps://doi.org/10.1016/j.ijnurstu.2020.103629
020-7489/© 2020 The Author(s). Published by Elsevier Ltd. This is an open access article
http://creativecommons.org/licenses/by-nc-nd/4.0/ )
hat this paper adds
• In the community, masks may be more protective for well peo- ple.
• In healthcare settings continuous use of respirators, is more protective compared to the medical masks, and medical masks
are more protective than cloth masks. Depending on the fabric
and design, some cloth masks may not be safe for healthcare
workers.
• The use of masks by sick patients is likely protective, and coro- naviruses can be emitted in normal breathing, in fine airborne
particles.
under the CC BY-NC-ND license.
2 C.R. MacIntyre and A .A . Chughtai / International Journal of Nursing Studies 108 (2020) 103629
Fig. 1. Search strategy and selection of papers.
2
2
p
h
d
t
p
e
a
b
e
t
t
t
c
f
s
r
s
w
g
c
j
p
H
s
i
t
i
e
y
e
t
s
v
i
v
e
1. Introduction
The use of personal protective equipment for coronavirus dis-
ease (COVID-19) has been controversial, with differing guidelines
issued by different agencies ( Chen et al., 2020 ). COVID-19 is caused
by severe acute respiratory syndrome coronavirus2 (SARS-CoV-2),
a beta-coronavirus, similar to severe acute respiratory syndrome
coronavirus (SARS CoV) ( Chen et al., 2020 ). Seasonal alpha and
beta coronaviruses cause common colds, croup and broncholitis.
The transmission mode of coronaviruses in humans is similar,
thought to be by droplet, contact and sometimes airborne routes
( Ong et al., 2020 ; Zhang et al., 2020 ; Zou et al., 2020 ). The World
Health Organization recommends surgical mask for health work-
ers providing routine care to a coronavirus disease patient ( World
Health Organisation (WHO) 2020 ), whilst the US Centers for Dis-
ease Control and Prevention recommended a respirator ( Center for
Disease Control and Prevention CDC, 2020 ). Most authorities, ex-
cept the US CDC, are recommending that community members not
wear a mask, and that a mask should only be worn by a sick pa-
tient (also referred to as source control ) ( Chughtai et al., 2020 ).
There are more randomised controlled trials of community use of
masks in well people than studies of the use by sick people ( source
control ). The aim of this study was to review the randomised con-
trolled trials evidence for use of masks and respirators by the com-
munity, health care workers and sick patients for prevention of in-
fection.
2. Methods
We searched Medline and EmBase for clinical trials on masks
and respirators using the key words “mask”, “respirator”, and “per-
sonal protective equipment”. The search was conducted between 1
March to April 17 2020, and all randomised controlled trials pub-
lished before the search date were included. Two authors (CRM
and AAC) reviewed the title and abstracts to identify randomised
controlled trials on masks and respirators. We also searched rel-
evant papers from the reference lists of previous clinical trials
and systematic reviews. Studies that were not randomised con-
trolled trials, were about anesthesia, or not about prevention of in-
fection were excluded. Animal studies, experimental and observa-
tional epidemiologic studies were also excluded. Studies published
in English language were included.
We found 602 papers on Medline and 250 on Embase. 820 pa-
pers were excluded by title and abstract review. Full texts were re-
viewed for 32 papers and 19 were selected in this review. Results
were reported according to the Preferred Reporting Items for Sys-
tematic Reviews and Meta-Analyses (PRISMA) criteria ( Moher et al.,
2015 ).
3. Results
In general, the results show protection for healthcare work-
ers and community members, and likely benefit of masks used as
source control. We found eight clinical trials ( Aiello et al., 2012 ;
Simmerman et al., 2011 ; Larson et al., 2010 ; Aiello et al., 2010 ;
MacIntyre et al., 2009 ; Cowling et al., 2008 , Suess et al., 2012 ;
Cowling et al., 2009 ) on the use of masks in the community
( Table 1 ). In the community, masks appear to be effective with
and without hand hygiene, and both together are more protec-
tive ( Aiello et al., 2012 ; Aiello et al., 2010 ; MacIntyre et al., 2009).
However, some randomised controlled trials which measured both
hand hygiene and masks measured the effect of hand hygiene
alone, but not of masks alone ( Simmerman et al., 2011 , Cowling
et al., 2009 ). In more than one trial, interventions had to be used
within 36 hours of exposure to be effective ( Cowling et al., 2009 ;
Suess et al., 2012 ).
To date, six randomised controlled trials ( Radonovich et al.,
019 ; Jacobs et al., 2009 , Loeb et al., 2009; MacIntyre et al., 2011,
013, 2015 ) have been conducted on the use of masks and/or res-
irators by healthcare workers in health care settings ( Table 2 ). The
ealthcare worker trials ( Table 2 ) used different interventions and
ifferent outcome measures, and one was in the outpatient set-
ing. A Japanese study had only 32 subjects, and likely was under-
owered to find any difference between masks and control ( Jacobs
t al., 2009 ). Two North American trials of masks and respirators
gainst influenza infection found no difference between the arms,
ut neither had a control arm to differentiate equal efficacy from
qual inefficacy ( Radonovich et al., 2019 , Loeb et al., 2009 ). Nei-
her trial can prove equivalence, as this requires one intervention
o be already proven efficaceous against placebo. Without a con-
rol group to determine rates of influenza in unprotected health-
are workers, neither study is able to determine efficacy if no dif-
erence was observed between the two interventions. A serologic
tudy showed that up to 23% of unprotected healthcare workers (a
ate identical to that observed in Loeb the trial, which also used
erology) contract influenza during outbreaks ( Elder et al., 1996 ),
hich suggests lack of efficacy. Studies of nosocomial influenza
enerally find lower influenza attack rates in unprotected health-
are workers than observed in the Loeb trial ( Salgado et al., 2002 ).
Further problems with this study are that the majority of sub-
ects were defined as having influenza on the basis of serological
ositivity ( Loeb et al., 2009 ). The 10% seroconversion to pandemic
1N109 (with no pandemic virus isolation or positive PCR) ob-
erved in the trial, suggests that pandemic H1N109 was circulating
n Ontario before April 2009, which is unlikely.
A serological definition of influenza can be affected by vaccina-
ion. The authors claim they excluded influenza vaccinated subjects
n the outcome, but according to figure 1 in the Loeb trial, ( Loeb
t al., 2009 ) these subjects (130 in total) are included in the anal-
sis. If they had been excluded and even if no other subjects were
xcluded, the total analysed would be 348, which is lower than
he 422 subjects analysed ( Loeb et al., 2009 ). These 130 vaccinated
ubjects should have been excluded entirely from the analysis. The
accination status of subjects with seropositivity is not provided
n the paper, but it appears people with positive serology due to
accination may have been misclassified as influenza cases ( Loeb
t al., 2009 ).
C.R. MacIntyre and A .A . Chughtai / International Journal of Nursing Studies 108 (2020) 103629 3
Table 1
Community mask trials.
Author, year N, country Interventions Results
Cowling et al. (2008) 198 Households
Hong Kong
Medical masks
Hand washing
Control
NS – this was a preliminary report of the 2009 trial.
MacIntyre et al. (2009) 143 Households
Australia
Medical masks
P2 masks
Control
Intention to treat non-significant. Adherence with mask
wearing low (25-30% by day 5). In sub-analysis,
masks/P2 protective if adherent.
Cowling et al., 2009 ) 407 households
Hong Kong
Hand hygiene
Masks + hand hygiene Control
Intention to treat not significant. Masks plus hand hygiene
protective against lab confirmed influenza if used within
36 hours. Hand hygiene alone not significant.
Aiello et al. (2010 ) 1437 college students, United
States of America
Masks Masks + hand washing
Control
Intention to treat non-significant. Masks + handwashing protective in week 4 -6 of observation and beyond.
Aiello et al. (2012 ) 1178 college students, United
States of America
Masks
Masks + hand hygiene Control
Intention to treat non-significant. Masks + hand hygiene protective in week 3 of observation and beyond. Masks
alone not protective.
Larson et al. (2010 ) 617 households, United States of
America
Health education (HE)
Hand hygiene + HE Masks + hand hygiene + HE
Masks + hand hygiene + HE protective against secondary transmission measured by confirmed influenza and ILI.
Mean secondary attack rates for HE, HE + HH, HE + HH + M groups were 0.023, 0.020, and 0.018, respectively
Simmerman et al. (2011 ) 465 index patients and their
families, Thailand
Hand hygiene
Masks + hand hygiene Control
No significant difference in confirmed influenza infection
Suess et al. (2012) 84 index cases and 218
household contacts, Germany
Masks
Masks + hand hygiene Control
Intention to treat analysis was non-significant. Where used
within 36 h, secondary infection in the pooled M and
MH groups was significantly lower compared to the
control group. In multivariable analysis for predictors of
qRT-PCR confirmed influenza infection and clinical
influenza among included households in separate models
allowing for within household correlation, M and MH
were protective against Influenza AH1N1pdm09.
Table 2
Trials of mask and respirator use by health care workers.
Author, year N healthcare workers, Country Interventions Results
Jacobs et al. (2009) 32
Japan
Medical masks
Control
NS
Loeb et al. (2009) 446
Canada
Medical masks, targeted N95 No significant difference between Masks and targeted
N95
MacIntyre et al. (2011) 1441
China
Masks
N95 respirators, fit tested
N95 respirators, non-fit tested
Control
Continuous N95 protective against clinical, viral and
bacterial endpoints
MacIntyre et al. (2013) 1669
China
Medical Mask
N95 (continuous)
N95 (targeted)
Continuous N95 protective
No difference between targeted N95 and medical
masks
MacIntyre et al. (2015) 1607
Vietnam
Medical masks, cloth masks,
control
Medical masks protective or Cloth masks increase risk of
infection
Radonovich et al. (2019 ) 2862
United States of America
Medical masks, targeted
N95 (when 2 m from
confirmed respiratory
infection) in Outpatient
setting.
No significant difference between
Masks and targeted N95
w
I
e
o
d
t
p
u
T
t
t
s
e
s
p
p
d
f
fi
2
p
i
r
c
C
w
2
2
In both the North American trials, the intervention comprised
earing the mask or respirator when in contact with recognized
LI or when doing a high risk procedure, which is a targeted strat-
gy ( Radonovich et al., 2019 , Loeb et al., 2009 ). One was in an
utpatient setting. ( Radonovich et al., 2019 ) We conducted a ran-
omised controlled trial comparing the targeted strategy tested in
he two North American studies, with the wearing of respiratory
rotection during an entire shift, and showed efficacy for contin-
al (but not targeted) use of a respirator ( MacIntyre et al., 2013 ).
he study also did not show efficacy for a surgical mask worn con-
inually, and therefore no difference between a surgical mask and
argeted use of a respirator ( MacIntyre et al., 2013 ), which is con-
istent with the findings of the North American trials ( Radonovich
t al., 2019 , Loeb et al., 2009 ). In summary, the evidence is con-
istent that a respirator must be worn throughout the shift to be
rotective. Targeted use of respirators only when doing high risk
rocedures and medical mask use is not protective. Another ran-
omised controlled trial we conducted in China showed efficacy
or continual use of a respirator, but not for a mask, and also found
t-testing of the respirator did not affect efficacy ( MacIntyre et al.,
011 ). However, this may be specific to the quality of the tested
roduct, and is not generalisable to other respirators – fit testing
s a necessary part of respirator use ( Chughtai et al., 2015 ).
For healthcare workers, there is evidence of efficacy of respi-
ators if worn continually during a shift, but no evidence of effi-
acy of a mask ( MacIntyre et al., 2011, 2013 ). For hospitals where
OVID-19 patients are being treated, there is growing evidence of
idespread contamination of the ward environment, well beyond
m from the patient, as well as aerosol transmission ( Ong et al.,
020 ; Santarpia et al., n.d. ; Guo et al., 2020 ). Several studies have
4 C.R. MacIntyre and A .A . Chughtai / International Journal of Nursing Studies 108 (2020) 103629
Table 3
Trials of Masks used by a sick patient as source control.
Author, year N , country Interventions Results
Johnson et al. (2009 ) 9 subjects with confirmed influenza,
Australia
Medical mask
N95 (participants coughed 5 times onto
a Petri dish wearing each device)
NS - Surgical and N95 masks were equally
effective in preventing the spread of
PCR-detectable influenza
Canini et al. (2010) 105 index cases and 306 household
contacts, France
Medical mask
Control
No significant difference, but trial
terminated early
MacIntyre et al. (2016) 245 index cases and 597 household
contacts,
Medical mask worn by sick case
Control (no mask) Household contacts
Followed for infection.
Intention to treat analysis not significant.
Mask protective if worn
Barasheed et al. (2014) Hajj Setting. 22 tents were randomised to
‘mask’ ( n = 12) or ‘control’ ( n = 10) 75 pilgrims in ‘mask’ and 89 in ‘control’
group
Saudi Arabia
Mask and control Less ILI among the contacts of mask users
compared to the control tents (31%
versus 53%, p = 0.04). Laboratory results did not show any
difference between the two groups
Leung et al. (2020 ) Experimental study of 246 subjects
randomised to surgical mask and no
mask
Mask and control 111 were infected by human (seasonal)
coronavirus. Coronavirus found in
exhaled breath of no-mask subjects but
not in mask wearers. More virus was
found in fine aerosols than large
droplets
s
p
m
b
4
o
2
C
s
t
(
T
s
e
e
e
p
c
a
u
w
q
b
u
(
f
t
H
a
t
t
s
A
r
w
e
t
e
c
c
h
found SARS-CoV-2 on air vents and in air samples in intensive care
units and COVID-19 wards ( Santarpia et al., n.d. ; Chia et al., 2020 ;
Liu et al., 2020 ), and an experimental study showed the virus in
air samples three hours after aerosolization ( van Doremalen et al.,
2020 ). The weight of this evidence and the precautionary princi-
ple ( MacIntyre et al., 2014 a; 2014 b), favors respirators for health-
care workers. We showed lower rates of infection outcomes in the
medical mask arm compared to control, but the difference was not
significant ( MacIntyre et al., 2011 ). It could be that larger trials are
needed to demonstrate efficacy of a mask, but any protection is far
less than from a respirator. A trial we conducted in Vietnam of 2-
layered cotton cloth masks compared to medical masks showed a
lower rate of infection in the medical mask group, and a 13 times
higher risk of infection in the cloth mask arm ( MacIntyre et al.,
2015 ). The study suggests cloth masks may increase the risk of in-
fection ( MacIntyre et al., 2015 ), but may not be generalizable to
all homemade masks. The material, design and adequacy of wash-
ing of cloth masks may have been a factor ( Macintyre et al., 2020 ).
There are no other randomised controlled trial of cloth masks pub-
lished at this time, but if any protection is offered by these it
would be less than even a medical mask.
Table 3 shows the trials of source control. There were five ran-
domised controlled trials identified of masks used by sick patients
( Johnson et al., 2009 , Barasheed et al., 2014; Leung et al., 2020;
MacIntyre et al., 2016; Canini et al., 2010 ). One was an experi-
mental study of 9 influenza patients, which did not measure clin-
ical endpoints ( Johnson et al., 2009 ). Participants with confirmed
influenza coughed onto culture medium wearing a N95 respira-
tor or a mask. No influenza grew on the medium. A trial of 105
sick patients wearing a mask (or no mask) in the household found
no significant difference between arms ( Canini et al., 2010 ). How-
ever, the trial was terminated prematurely and did not meet re-
cruitment targets, so was probably underpowered. One randomised
controlled trial was conducted among Hajj pilgrims, with both well
and sick pilgrims wearing masks, and low rates of ILI were re-
ported among contact of mask pilgrims ( Barasheed et al., 2014 ).
Our randomised controlled trial is the largest available with clinical
endpoints, and studied 245 patients randomised to mask or control
( MacIntyre et al., 2016 ). Compliance was suboptimal in the mask
group and some controls wore masks. The intention to treat anal-
ysis showed no difference, but when analysed by actual mask use,
the rate of infection in household contacts was lower in those who
wore masks ( MacIntyre et al., 2016 ). A trial with an experimental
design was published in April 2020, examining a range of viruses
including seasonal human coronaviruses ( Leung et al., 2020 ). This
howed that coronaviruses are preferentially found in aerosolized
articles compared to large droplets, and could be expelled by nor-
al tidal breathing. Wearing a surgical mask prevented virus from
eing exhaled.
. Discussion
There are more randomised controlled trials of community use
f masks in well people ( Aiello et al., 2012 ; Simmerman et al.,
011 ; Larson et al., 2010 ; Aiello et al., 2010 ; MacIntyre et al., 2009 ;
owling et al., 2008 , Suess et al., 2012 , Cowling et al., 2009 ) than
tudies of the use by sick people (also referred to as “source con-
rol”), and these trials are larger than the few on source control
Johnson et al., 2009 , Leung et al., 2020; MacIntyre et al., 2016 ).
he evidence suggests protection by masks in high transmission
ettings such as household and college settings, especially if used
arly, in some trials if combined with hand hygiene and if wear-
rs are compliant ( Aiello et al., 2012 ; Aiello et al., 2010 ; MacIntyre
t al., 2009 ; Cowling et al., 20 08, 20 09; Suess et al., 2012 ). If masks
rotect in high transmission settings, they should also protect in
rowded public spaces, including workplaces, buses, trains, planes
nd other closed settings. The trial which did not show efficacy
sed influenza as the outcome measure ( Simmerman et al., 2011 ),
hich is a rare outcome, so requires a larger sample size for ade-
uate power and may have been underpowered.
For healthcare workers, the only trials to show a difference
etween respirators and masks demonstrated efficacy for contin-
ous use of a respirator through a clinical shift, but not masks
MacIntyre et al., 2011, 2013 ). The two trials which showed no dif-
erence are widely cited as evidence that masks provide equal pro-
ection as respirators ( Radonovich et al., 2019 , Loeb et al., 2009 ).
owever, without a control arm, the absence of difference between
rms could reflect equal efficacy or inefficacy, and it is not possible
o draw any conclusions about efficacy. The outpatient setting in
he US trial may have had lower exposure risk than the inpatient
etting of other trials. ( Radonovich et al., 2019 ) In both the North
merican trials, the intervention comprised wearing the mask or
espirator intermittently when in contact with recognized ILI or
hen doing a high risk procedure ( Radonovich et al., 2019 , Loeb
t al., 2009 ). The underlying assumption that the majority of infec-
ions in healthcare workers occur during self-identified high-risk
xposures is not supported by any evidence. It assumes health-
are workers can accurately identify when they are risk in a busy,
linical setting, when the majority of infections may occur when
ealthcare workers are unaware of the risk (such as when walking
C.R. MacIntyre and A .A . Chughtai / International Journal of Nursing Studies 108 (2020) 103629 5
t
m
w
n
c
w
d
b
I
t
h
b
n
f
l
u
b
m
2
a
t
fi
2
a
M
r
2
e
e
g
h
w
m
c
T
c
t
c
b
u
h
u
n
s
t
c
s
o
e
p
a
a
t
n
2
m
(
1
p
u
p
a
t
(
a
p
e
t
C
R
c
a
f
i
o
F
F
R
A
A
A
B
B
B
C
C
C
C
C
C
C
C
C
hrough a busy emergency room or ward where aerosolized virus
ay be present). Conversely, infections could occur outside the
orkplace. This could explain the lack of difference if there was
o actual efficacy of either arm and if much of the infection oc-
urs in unrecognized situations of risk either within or outside the
orkplace.
In practice, hospital infection control divides infections into
roplet or airborne spread, and recommends droplet (mask) or air-
orne (respirator) precautions accordingly ( MacIntyre et al., 2017 ).
n a pooled analysis of both healthcare worker trials, we showed
hat continual use of a respirator is more efficacious in protecting
ealthcare workers even against infections assumed to be spread
y the droplet route ( MacIntyre et al., 2017 ). Medical masks did
ot significantly protect against viral, bacterial, droplet or other in-
ection outcomes. However, the summary odds ratio for masks was
ess than one, which suggests a low level of protection. Targeted
se of respirator protected against bacterial and droplet infections,
ut not against viral infections, suggesting viral infections may be
ore likely to be airborne in the hospital setting ( MacIntyre et al.,
017 ).
The five available studies of mask use by sick patients suggest
benefit, but are much smaller trials than the community trials,
wo without clinical endpoints, and with less certainty around the
ndings ( Johnson et al., 2009 , Barasheed et al., 2014; Leung et al.,
020; MacIntyre et al., 2016; Canini et al., 2010 ). Only 3/5 trials ex-
mined clinical outcomes in close contacts ( Barasheed et al., 2014;
acIntyre et al., 2016; Canini et al., 2010 ) and suggest a benefit
Many systematic reviews have been conducted on masks, respi-
ators and other PPE in past ( Cowling et al., 2010 ; Bin-Reza et al.,
012 ; Gralton and McLaws, 2010 ; Gamage et al., 2005 ; Jefferson
t al., 2009 ; Jefferson et al., 2011 ; Jefferson et al., 2008 ; Aledort
t al., 2007 ; Lee et al., 2011 ; Verbeek et al., 2020 ). These reviews
enerally examined multiple interventions (e.g. masks and hand
ygiene etc.), often combined different outcome measures that
ere not directly comparable and were inconclusive. Moreover,
ost of these reviews did not include more recent randomised
ontrolled trials ( Radonovich et al., 2019 , MacIntyre et al., 2015 ).
his systematic review only focuses on masks and respirators and
ontains all new studies.
In summary, there is a growing body of evidence supporting all
hree indications for respiratory protection – community, health-
are workers and sick patients (source control). The largest num-
er of randomised controlled trials have been done for community
se of masks by well people in high-transmission settings such as
ousehold or college settings. There is benefit in the community if
sed early, with hand hygiene and if compliant.
Respirators protect healthcare workers if worn continually, but
ot if worn intermittently in self-identified situations of risk. This
upports the suggestion that the health care environment is a risk
o healthcare workers even when not doing aerosol generating pro-
edures or caring for a known infectious patient. For COVID-19
pecifically, the growing body of evidence showing aerosolisation
f the virus in the hospital ward highlights the risk of inadvertent
xposure for healthcare workers and supports the use of airborne
recautions at all times on the ward ( Santarpia et al., n.d. ; Chia et
l., 2020 ; Liu et al., 2020 ). Further, the rule of 1–2 m of spatial sep-
ration is not based on good evidence, with most research showing
hat droplets can travel further than 2 m, and that infections can-
ot be neatly separated into droplet and airborne ( MacIntyre et al.,
017 ; Bahl et al., 2020 ). In the UK, one healthcare trust found al-
ost one in five healthcare workers to be infected with COVID-19
Keeley et al., 2020 ). The deaths of healthcare workers from COVID-
9 reflect this risk ( Zhan et al., 2020 ). The use of masks by sick
eople, despite being the WHO’s only recommendation for mask
se by community members during COVID-19 pandemic, is sup-
orted by the smallest body of evidence. Source control is prob-
bly a sensible recommendation given the suggestion of protec-
ion and given specific data on coronaviruses showing protection
Leung et al., 2020 ). It may help if visitors and febrile patients wear
mask in the healthcare setting, whether in primary care or hos-
itals. Universal face mask use is likely to have the most impact on
pidemic growth in the community, given the high risk of asymp-
omatic and pre-symptomatic transmission ( He et al., 2020 ).
onflict of Interest
C Raina MacIntyre receives funding from NHMRC (centre for
esearch Excellence and Principal Research Fellowship) and Sanofi
urrently. She has received funding from 3M more than 10 years
go for face mask research.
Abrar Ahmad Chughtai had testing of filtration of masks by 3M
or his Ph.D. more than 10 years ago. 3M products were not used
n his research. He also has worked with CleanSpace Technology
n research on fit testing of respirators (no funding was involved).
unding
C Raina MacIntyre is supported by a NHMRC Principal Research
ellowship, grant number 1137582.
eferences
iello, A.E. , Perez, V. , Coulborn, R.M. , Davis, B.M. , Uddin, M. , Monto, A.S. , 2012. Face- masks, hand hygiene, and influenza among young adults: a randomized inter-
vention trial. PLoS ONE 7 (1) . iello, A.E. , Murray, G.F. , Perez, V. , Coulborn, R.M. , Davis, B.M. , Uddin, M. , et al. ,
2010. Mask use, hand hygiene, and seasonal influenza-like illness among young adults: a randomized intervention trial. J. Infect. Dis. 201 (4), 4 91–4 98 .
ledort, J.E. , Lurie, N. , Wasserman, J. , Bozzette, S.A. , 2007. Non-pharmaceutical pub-
lic health interventions for pandemic influenza: an evaluation of the evidence base. BMC Public Health 7, 208 .
ahl, P. , Doolan, C. , de Silva, C. , Chughtai, A .A . , Bourouiba, L. , MacIntyre, C.R. , 2020. Airborne or droplet precautions for health workers treating COVID-19? J. Infect.
Dis. . arasheed, O. , Almasri, N. , Badahdah, A.M. , Heron, L. , Taylor, J. , McPhee, K. , et al. ,
2014. Pilot randomised controlled trial to test effectiveness of facemasks in pre-
venting influenza-like illness transmission among Australian Hajj Pilgrims in 2011. Infect. Disord. Drug Targets. 14 (2), 110–116 .
in-Reza, F. , Lopez Chavarrias, V. , Nicoll, A. , Chamberland, M.E. , 2012. The use of masks and respirators to prevent transmission of influenza: a systematic review
of the scientific evidence. Influenza Other Respir. Viruses 6 (4), 257–267 . anini L., Andreoletti L., Ferrari P., D’Angelo R., Blanchon T., Lemaitre M., et al. Surgi-
cal mask to prevent influenza transmission in households: a cluster randomized
trial. PLoS ONE [Electronic Resource]. 2010. 5(11):e13998. hen, N. , Zhou, M. , Dong, X. , Qu, J. , Gong, F. , Han, Y. , et al. , 2020. Epidemiological
and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet 395 (10223), 507–513 .
enter for Disease Control and Prevention (CDC). Interim healthcare infection pre- vention and control recommendations for patients under investigation for 2019
novel coronavirus. 2020. January 2020 [Available from: https://www.cdc.gov/
coronavirus/2019- nCoV/infection- control.html . hughtai, A .A . , Seale, H. , Islam, M.S. , Owais, M. , Macintyre, C.R. , 2020. Policies on
the use of respiratory protection for hospital health workers to protect from coronavirus disease (COVID-19). Int. J. Nurs. Stud. 105, 103567 .
hia, P.Y., Coleman, K.K., Tan, Y.K., Ong, S.W.X., Gum, M., Lau, S.K., et al., 2020. De- tection of Air and Surface Contamination by Severe Acute Respiratory Syndrome
Coronavirus 2 (SARS-CoV-2) in Hospital Rooms of Infected Patients. medRxiv
doi: 10.1101/2020.03.29.20046557 . hughtai, A .A . , MacIntyre, C.R. , Zheng, Y. , Wang, Q. , Toor, Z.I. , Dung, T.C. , et al. , 2015.
Examining the policies and guidelines around the use of masks and respirators by healthcare workers in China, Pakistan and Vietnam. J. Infect. Prev. 16 (2),
68–74 . owling, B.J. , Chan, K.H. , Fang, V.J. , Cheng, C.K. , Fung, R.O. , Wai, W. , et al. , 2009.
Facemasks and hand hygiene to prevent influenza transmission in households: a cluster randomized trial. Ann. Intern. Med. 151 (7), 437–446 .
owling, B.J. , Fung, R.O. , Cheng, C.K. , Fang, V.J. , Chan, K.H. , Seto, W.H. , et al. , 2008.
Preliminary findings of a randomized trial of non-pharmaceutical interventions to prevent influenza transmission in households. PLoS ONE 3 (5), e2101 .
owling, B.J. , Zhou, Y. , Ip, D.K. , Leung, G.M. , Aiello, A.E. , 2010. Face masks to prevent transmission of influenza virus: a systematic review. Epidemiol. Infect. 138 (4),
449–456 .
6 C.R. MacIntyre and A .A . Chughtai / International Journal of Nursing Studies 108 (2020) 103629
M
M
M
M
O
R
S
S
S
V
W
Z
Z
Z
Elder, A.G. , O’Donnell, B. , McCruden, E.A. , Symington, I.S. , Carman, W.F. , 1996. Inci- dence and recall of influenza in a cohort of Glasgow healthcare workers during
the 1993-4 epidemic: results of serum testing and questionnaire. BMJ (Clin. Res. Ed.) 313 (7067), 1241–1242 .
Gamage, B. , Moore, D. , Copes, R. , Yassi, A. , Bryce, E. , 2005. Protecting health care workers from SARS and other respiratory pathogens: a review of the infection
control literature. Am. J. Infect. Control 33 (2), 114–121 . Gralton, J. , McLaws, M.L. , 2010. Protecting healthcare workers from pandemic in-
fluenza: N95 or surgical masks? Crit. Care Med. 38 (2), 657–667 .
Guo, Z. , Wang, Z. , Zhang, S. , Li, X. , Li, L. , Li, C. , et al. , 2020. Aerosol and Surface Distribution of Severe Acute Respiratory Syndrome Coronavirus 2 in Hospital
Wards, Wuhan, China, 2020. Emerg. Infect. Dis. 26 (7) . He, X., Lau, E.H., Wu, P., Deng, X., Wang, J., Hao, X., et al., 2020. Temporal dynam-
ics in viral shedding and transmissibility of COVID-19. medRxiv doi: 10.1038/ s41591- 020- 0869- 5 .
Jacobs, J.L. , Ohde, S. , Takahashi, O. , Tokuda, Y. , Omata, F. , Fukui, T. , 2009. Use of
surgical face masks to reduce the incidence of the common cold among health care workers in Japan: a randomized controlled trial. Am. J. Infect. Control 37
(5), 417–419 . Jefferson, T. , Del Mar, C. , Dooley, L. , Ferroni, E. , Al-Ansary, L.A. , Bawazeer, G.A. , et al. ,
2009. Physical interventions to interrupt or reduce the spread of respiratory viruses: systematic review. BMJ (Clin. Res. Ed.) 339, b3675 .
Jefferson, T. , Del Mar, C.B. , Dooley, L. , Ferroni, E. , Al-Ansary, L.A. , Bawazeer, G.A. ,
et al. , 2011. Physical interventions to interrupt or reduce the spread of respi- ratory viruses. Cochr. Database Syst. Rev. (7), CD006207 .
Jefferson, T. , Foxlee, R. , Del Mar, C. , Dooley, L. , Ferroni, E. , Hewak, B. , et al. , 2008. Physical interventions to interrupt or reduce the spread of respiratory viruses:
systematic review. BMJ (Clin. Res. Ed.) 336 (7635), 77–80 . Johnson, D. , Druce, J.D. , Birch, C. , Grayson, M.L. , 2009. A quantitative assessment of
the efficacy of surgical and N95 masks to filter influenza virus in patients with
acute influenza infection. Clin. Infect. Dis. 49 (2), 275–277 . Keeley, A.J. , Evans, C. , Colton, H. , Ankcorn, M. , Cope, A. , Bennett, T. , et al. , 2020. Rol-
l-out of SARS-CoV-2 testing for healthcare workers at a large NHS Foundation Trust in the United Kingdom, March 2020. Eurosurveillance 25 (14), 20 0 0433 .
Larson, E.L. , Ferng, Y.-.H. , Wong-McLoughlin, J. , Wang, S. , Haber, M. , Morse, S.S. , 2010. Impact of non-pharmaceutical interventions on URIs and influenza in
crowded, urban households. Public Health Rep. 125 (2), 178–191 .
Lee K.M., Shukla V.K., Clark M., Mierzwinski-Urban M., Pessoa-Silva C.L., Conly J. Physical Interventions to Interrupt or Reduce the Spread of Respiratory Viruses -
Resource Use Implications: a Systematic Review. Ottawa ON: 2011 Cadth.; 2011 Dec.
Leung, N.H. , Chu, D.K. , Shiu, E.Y. , Chan, K.-.H. , McDevitt, J.J. , Hau, B.J. , et al. , 2020. Respiratory virus shedding in exhaled breath and efficacy of face masks. Nat.
Med. 1–5 .
Liu, Y., Ning, Z., Chen, Y., Guo, M., Liu, Y., Gali, N.K., et al., 2020. Aerodynamic char- acteristics and RNA concentration of SARS-CoV-2 aerosol in Wuhan hospitals
during COVID-19 outbreak. bioRxiv doi: 10.1101/2020.03.08.982637 . Loeb, M. , Dafoe, N. , Mahony, J. , John, M. , Sarabia, A. , Glavin, V. , et al. , 2009. Surgical
mask vs N95 respirator for preventing influenza among health care workers: a randomized trial. JAMA 302 (17), 1865–1871 .
MacIntyre, C.R. , Cauchemez, S. , Dwyer, D.E. , Seale, H. , Cheung, P. , Browne, G. , et al. , 2009. Face mask use and control of respiratory virus transmission in house-
holds. Emerg. Infect. Dis. 15 (2), 233 .
MacIntyre, C.R. , Chughtai, A .A . , Seale, H. , Richards, G.A. , Davidson, P.M. , 2014. Respi- ratory protection for healthcare workers treating Ebola virus disease (EVD): are
facemasks sufficient to meet occupational health and safety obligations? Int. J. Nurs. Stud. 51 (11), 1421–1426 .
MacIntyre, C.R. , Chughtai, A .A . , Seale, H. , Richards, G.A. , Davidson, P.M. , 2014. Uncer- tainty, risk analysis and change for Ebola personal protective equipment guide-
lines. Int. J. Nurs. Stud. 52 (5), 899–903 .
MacIntyre, C.R. , Chughtai, A .A . , Rahman, B. , Peng, Y. , Zhang, Y. , Seale, H. , et al. , 2017. The efficacy of medical masks and respirators against respiratory infection in
healthcare workers. Influenza Other Respir. Viruses 11 (6), 511–517 .
acintyre, R., Chughtai, A., Tham, C.D., Seale, H., 2020. Covid-19: Should cloth masks be used by healthcare workers as a last resort? BMJ (Clin.
Res. Ed.) [Internet][cited 2020]. https://blogs.bmj.com/bmj/2020/04/09/ covid- 19- should- cloth- masks- be- used- by- healthcare- workers- as- a- last- resort/ .
acIntyre, C.R. , Seale, H. , Dung, T.C. , Hien, N.T. , Nga, P.T. , Chughtai, A .A . , et al. , 2015. A cluster randomised trial of cloth masks compared with medical masks in
healthcare workers. BMJ Open 5 (4), e006577 . MacIntyre, C.R. , Wang, Q. , Cauchemez, S. , Seale, H. , Dwyer, D.E. , Yang, P. , et al. , 2011.
A cluster randomized clinical trial comparing fit-tested and non-fit-tested N95
respirators to medical masks to prevent respiratory virus infection in health care workers. Influenza Other Respir. Viruses 5 (3), 170–179 .
acIntyre, C.R. , Wang, Q. , Seale, H. , Yang, P. , Shi, W. , Gao, Z. , et al. , 2013. A ran- domized clinical trial of three options for N95 respirators and medical masks in
health workers. Am. J. Respir. Crit. Care Med. 187 (9), 960–966 . acIntyre, C.R. , Zhang, Y. , Chughtai, A .A . , Seale, H. , Zhang, D. , Chu, Y. , et al. , 2016.
Cluster randomised controlled trial to examine medical mask use as source con-
trol for people with respiratory illness. BMJ Open 6 (12), e012330 . Moher, D. , Shamseer, L. , Clarke, M. , Ghersi, D. , Liberati, A. , Petticrew, M. , et al. ,
2015. Preferred reporting items for systematic review and meta-analysis pro- tocols (PRISMA-P) 2015 statement. Syst. Rev. 4 (1), 1 .
ng, S.W.X., Tan, Y.K., Chia, P.Y., Lee, T.H., Ng, O.T., Wong, M.S.Y., et al., 2020. Air, sur- face environmental, and personal protective equipment contamination by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic
patient. JAMA: J. Am. Med. Assoc. doi: 10.1001/jama.2020.3227 . adonovich, L.J. , Simberkoff, M.S. , Bessesen, M.T. , Brown, A.C. , Cummings, D.A.T. ,
Gaydos, C.A. , et al. , 2019. N95 respirators vs medical masks for preventing in- fluenza among health care personnel: a randomized clinical trial. JAMA J. Am.
Med. Assoc. 322 (9), 824–833 . algado, C.D. , Farr, B.M. , Hall, K.K. , Hayden, F.G. , 2002. Influenza in the acute hospital
setting. Lancet Infect. Dis. 2 (3), 145–155 .
Santarpia, J.L., Rivera, D.N., Herrera, V., Morwitzer, M.J., Creager, H., Santarpia, G.W., et al., medRxiv. 2020. Transmission Potential of SARS-CoV-2 in Viral Shedding
Observed at the. University of Nebraska Medical Center doi: 10.1101/2020.03.23. 20039446 .
immerman, J.M. , Suntarattiwong, P. , Levy, J. , Jarman, R.G. , Kaewchana, S. , Gib- bons, R.V. , et al. , 2011. Findings from a household randomized controlled trial
of hand washing and face masks to reduce influenza transmission in Bangkok,
Thailand. Influenza Other Respir. Viruses 5 (4), 256–267 . uess, T. , Remschmidt, C. , Schink, S.B. , Schweiger, B. , Nitsche, A. , Schroeder, K. , et al. ,
2012. The role of facemasks and hand hygiene in the prevention of influenza transmission in households: results from a cluster randomised trial; Berlin, Ger-
many, 2009-2011. BMC Infect. Dis. 12, 26 . van Doremalen, N., Bushmaker, T., Morris, D.H., Holbrook, M.G., Gamble, A.,
Williamson, B.N., et al., 2020. Aerosol and surface stability of SARS-CoV-2 as
compared with SARS-CoV-1. New Engl. J. Med. 382 (16), 1564–1567. doi: 10. 1056/NEJMc2004973 .
erbeek, J.H. , Rajamaki, B. , Ijaz, S. , Sauni, R. , Toomey, E. , Blackwood, B. , et al. , 2020. Personal protective equipment for preventing highly infectious diseases due to
exposure to contaminated body fluids in healthcare staff. Cochr. Database Syst. Rev. (4) .
orld Health Organisation (WHO). Infection prevention and control during health care when novel coronavirus (nCoV) infection is suspected. Interim
guidance 2020 [Available from: https://www.who.int/publications- detail/
infection- prevention- and- control- during- health- care- when- novel- coronavirus- (ncov)- infection- is- suspected .
han, M., Qin, Y., Xue, X., Zhu, S., 2020. Death from Covid-19 of 23 Health Care Workers in China. New Engl. J. Med. doi: 10.1056/NEJMc2005696 .
hang, W. , Du, R.-.H. , Li, B. , Zheng, X.-.S. , Yang, X.-.L. , Hu, B. , et al. , 2020. Molecu- lar and serological investigation of 2019-nCoV infected patients: implication of
multiple shedding routes. Emerg. Microbes Infect. 9 (1), 386–389 .
ou, L., Ruan, F., Huang, M., Liang, L., Huang, H., Hong, Z., et al., 2020. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. New Engl. J. Med.
382 (12), 1177–1179. doi: 10.1056/NEJMc2001737 .